São Paulo – JBS entered the health and nutraceuticals market with the onset of the production of collagen peptides and gelatin. The global leader in protein-based foods, a supplier to the Arab countries, launched the Genu-in brand for the new business, which will serve customers from different regions, according to information disclosed by the company this Wednesday (10). The plant was installed in the city of Presidente Epitácio, in the interior of São Paulo state, and required investments of BRL 400 million (about USD 78,1 million at the current rate). Nutraceuticals are food compounds that provide health and nutritional benefits.
Genu-in uses bovine skin as raw input from JBS’s own production. The Brazilian company informed the initiative reinforces the circular economy front, with the transformation of by-products from the processing of its chains into products with high added value, such as leather, biodiesel, fertilizers, animal feed, pharmaceutical inputs, hygiene and cleaning supplies, among others.
“At Genu-in, production is integrated into the JBS value chain, which guarantees safety, sustainability, and reliability from the beginning to the end of the process,” said Cláudia Yamana (pictured above), director of Genu-in, in a release. The new company operates in the B2B market, focusing on selling peptides and gelatin for the food, pharmaceutical, and nutraceutical industries.
The first launch is the collagen peptide Genu-in Life, an ingredient for health and nutrition products to strengthen cartilages, tendons, muscles, and bones and enhance skin beauty. Genu-in Gel gelatine, used by the food industry and pharmaceuticals in developing medicine tablets and capsules, will also arrive on the market soon.
Translated by Elúsio Brasileiro
